PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-9

  1. 995 Posts.
    lightbulb Created with Sketch. 327
    Great news all, well done to us all

    Another step forward
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.